- Ana Sayfa
- Ücretsiz Uygulama Analitiği
- SARCULATOR
- SARCULATOR Vs. ASCO Guidelines
SARCULATOR vs ASCO Guidelines Kullanım & İstatistikleri
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
SARCULATOR ile ASCO Guidelines için sıralama karşılaştırması
Son 28 gündeki SARCULATOR sıralama trendini ASCO Guidelinesile karşılaştırın
Rank
Mevcut veri yok
SARCULATOR vs. ASCO Guidelines ülke karşılaştırmasına göre sıralama
Son 28 gündeki SARCULATOR sıralama trendini ASCO Guidelinesile karşılaştırın
Tüm kategoriler
Mevcut veri yok
Medikal
Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın
SARCULATOR VS.
ASCO Guidelines
Ocak 8, 2025